Grant of Interim Extension of the Term of U.S. Patent No. 8,260,416; OPTIMIZER® Smart Implantable Pulse Generator, 59364 [2018-25537]
Download as PDF
<![CDATA[
59364
Federal Register / Vol. 83, No. 226 / Friday, November 23, 2018 / Notices
Notice of interim patent term
extension.
ACTION:
The United States Patent and
Trademark Office has issued an order
granting interim extension for a oneyear interim extension of the term of
U.S. Patent No. 8,311,629.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Section
156 of Title 35, United States Code,
generally provides that the term of a
patent may be extended for a period of
up to five years if the patent claims a
product, or a method of making or using
a product, that has been subject to
certain defined regulatory review, and
that the patent may be extended for
interim periods of up to one year if the
regulatory review is anticipated to
extend beyond the expiration date of the
patent.
On October 26, 2018, Impulse
Dynamic N.V., the patent owner of
record, timely filed an application
under 35 U.S.C. 156(d)(5) for an interim
extension of the term of U.S. Patent No.
8,311,629. The patent claims the
medical device, the OPTIMIZER Smart
Implantable Pulse Generator. The
application for patent term extension
indicates that a Premarket Approval
Application (PMA) P180036 was
submitted to the Food and Drug
Administration (FDA) on September 5,
2018.
Review of the patent term extension
application indicates that, except for
permission to market or use the product
commercially, the subject patent would
be eligible for an extension of the patent
term under 35 U.S.C. 156, and that the
patent should be extended for one year
as required by 35 U.S.C. 156(d)(5)(B).
Because the regulatory review period
will continue beyond the original
expiration date of the patent, November
16, 2018, interim extension of the patent
term under 35 U.S.C. 156(d)(5) is
appropriate.
An interim extension under 35 U.S.C.
156(d)(5) of the term of U.S. Patent No.
8,311,629 is granted for a period of one
year from the original expiration date of
the patent.
amozie on DSK3GDR082PROD with NOTICES1
VerDate Sep<11>2014
18:33 Nov 21, 2018
Jkt 247001
[FR Doc. 2018–25539 Filed 11–21–18; 8:45 am]
BILLING CODE 3510–16–P
DEPARTMENT OF COMMERCE
Mary C. Till by telephone at (571) 272–
7755; by mail marked to her attention
and addressed to the Commissioner for
Patents, Mail Stop Hatch-Waxman PTE,
P.O. Box 1450, Alexandria, VA 22313–
1450; by fax marked to her attention at
(571) 273–7755; or by email to
Mary.Till@uspto.gov.
SUPPLEMENTARY INFORMATION:
Dated: November 15, 2018.
Robert Bahr,
Deputy Commissioner for Patent Examination
Policy, United States Patent and Trademark
Office.
Patent and Trademark Office
[Docket No.: PTO–P–2018–0064]
Grant of Interim Extension of the Term
of U.S. Patent No. 8,260,416;
OPTIMIZER® Smart Implantable Pulse
Generator
United States Patent and
Trademark Office, Commerce.
ACTION: Notice of interim patent term
extension.
AGENCY:
The United States Patent and
Trademark Office has issued an order
granting interim extension for a oneyear interim extension of the term of
U.S. Patent No. 8,260,416.
FOR FURTHER INFORMATION CONTACT:
Mary C. Till by telephone at (571) 272–
7755; by mail marked to her attention
and addressed to the Commissioner for
Patents, Mail Stop Hatch-Waxman PTE,
P.O. Box 1450, Alexandria, VA 22313–
1450; by fax marked to her attention at
(571) 273–7755; or by email to
Mary.Till@uspto.gov.
SUPPLEMENTARY INFORMATION: Section
156 of Title 35, United States Code,
generally provides that the term of a
patent may be extended for a period of
up to five years if the patent claims a
product, or a method of making or using
a product, that has been subject to
certain defined regulatory review, and
that the patent may be extended for
interim periods of up to one year if the
regulatory review is anticipated to
extend beyond the expiration date of the
patent.
On October 26, 2018, Impulse
Dynamic N.V., the patent owner of
record, timely filed an application
under 35 U.S.C. 156(d)(5) for an interim
extension of the term of U.S. Patent No.
8,260,416. The patent claims methods of
using the medical device, the
OPTIMIZER Smart Implantable Pulse
Generator. The application for patent
term extension indicates that a
Premarket Approval Application (PMA)
P180036 was submitted to the Food and
Drug Administration (FDA) on
September 5, 2018.
Review of the patent term extension
application indicates that, except for
permission to market or use the product
commercially, the subject patent would
be eligible for an extension of the patent
term under 35 U.S.C. 156, and that the
patent should be extended for one year
as required by 35 U.S.C. 156(d)(5)(B).
Because the regulatory review period
will continue beyond the original
expiration date of the patent, November
19, 2018, interim extension of the patent
term under 35 U.S.C. 156(d)(5) is
appropriate.
An interim extension under 35 U.S.C.
156(d)(5) of the term of U.S. Patent No.
8,260,416 is granted for a period of one
year from the original expiration date of
the patent.
Dated: November 15, 2018.
Robert Bahr,
Deputy Commissioner for Patent Examination
Policy, United States Patent and Trademark
Office.
[FR Doc. 2018–25537 Filed 11–21–18; 8:45 am]
BILLING CODE 3510–16–P
SUMMARY:
PO 00000
Frm 00011
Fmt 4703
Sfmt 4703
DEPARTMENT OF DEFENSE
Department of the Army
Army Education Advisory
Subcommittee Meeting Notice
Department of the Army, DoD.
Notice of open subcommittee
meeting.
AGENCY:
ACTION:
The Department of the Army
is publishing this notice to announce
the following Federal advisory
committee meeting of the Defense
Language Institute Foreign Language
Center Board of Visitors, a
subcommittee of the Army Education
Advisory Committee. This meeting is
open to the public.
DATES: The Defense Language Institute
Foreign Language Center (DLIFLC)
Board of Visitors Subcommittee will
meet from 8:00 a.m. to 5:00 p.m. on
December 12 and 13, 2018.
ADDRESSES: Defense Language Institute
Foreign Language Center, Building 326,
Weckerling Center, Presidio of
Monterey, CA 93944.
FOR FURTHER INFORMATION CONTACT: Mr.
Detlev Kesten, the Alternate Designated
Federal Officer for the subcommittee, in
writing at Defense Language Institute
Foreign Language Center, ATFL–APAS–
AA, Bldg. 614, Presidio of Monterey, CA
93944, by email at Detlev.kesten@
dliflc.edu, or by telephone at (831) 242–
6670.
SUPPLEMENTARY INFORMATION: The
subcommittee meeting is being held
under the provisions of the Federal
Advisory Committee Act of 1972 (5
U.S.C., Appendix, as amended), the
Government in the Sunshine Act of
SUMMARY:
E:\FR\FM\23NON1.SGM
23NON1
]]>Agencies
[Federal Register Volume 83, Number 226 (Friday, November 23, 2018)]
[Notices]
[Page 59364]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25537]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Patent and Trademark Office
[Docket No.: PTO-P-2018-0064]
Grant of Interim Extension of the Term of U.S. Patent No.
8,260,416; OPTIMIZER[supreg] Smart Implantable Pulse Generator
AGENCY: United States Patent and Trademark Office, Commerce.
ACTION: Notice of interim patent term extension.
-----------------------------------------------------------------------
SUMMARY: The United States Patent and Trademark Office has issued an
order granting interim extension for a one-year interim extension of
the term of U.S. Patent No. 8,260,416.
FOR FURTHER INFORMATION CONTACT: Mary C. Till by telephone at (571)
272-7755; by mail marked to her attention and addressed to the
Commissioner for Patents, Mail Stop Hatch-Waxman PTE, P.O. Box 1450,
Alexandria, VA 22313-1450; by fax marked to her attention at (571) 273-
7755; or by email to [email protected].
SUPPLEMENTARY INFORMATION: Section 156 of Title 35, United States Code,
generally provides that the term of a patent may be extended for a
period of up to five years if the patent claims a product, or a method
of making or using a product, that has been subject to certain defined
regulatory review, and that the patent may be extended for interim
periods of up to one year if the regulatory review is anticipated to
extend beyond the expiration date of the patent.
On October 26, 2018, Impulse Dynamic N.V., the patent owner of
record, timely filed an application under 35 U.S.C. 156(d)(5) for an
interim extension of the term of U.S. Patent No. 8,260,416. The patent
claims methods of using the medical device, the OPTIMIZER Smart
Implantable Pulse Generator. The application for patent term extension
indicates that a Premarket Approval Application (PMA) P180036 was
submitted to the Food and Drug Administration (FDA) on September 5,
2018.
Review of the patent term extension application indicates that,
except for permission to market or use the product commercially, the
subject patent would be eligible for an extension of the patent term
under 35 U.S.C. 156, and that the patent should be extended for one
year as required by 35 U.S.C. 156(d)(5)(B). Because the regulatory
review period will continue beyond the original expiration date of the
patent, November 19, 2018, interim extension of the patent term under
35 U.S.C. 156(d)(5) is appropriate.
An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S.
Patent No. 8,260,416 is granted for a period of one year from the
original expiration date of the patent.
Dated: November 15, 2018.
Robert Bahr,
Deputy Commissioner for Patent Examination Policy, United States Patent
and Trademark Office.
[FR Doc. 2018-25537 Filed 11-21-18; 8:45 am]
BILLING CODE 3510-16-P
